isabelobrien, Author at European Medical Journal - Page 57 of 66

Talking to Nancy Globus

Nancy Globus, Vice President for Regulatory and Medicine Safety, Addison Whitney, talks medication safety, product labelling and errors.

The 2021 pharma forecast

Looking forward to the year ahead, GOLD casts five predictions for what the standout advancements and priorities will be for pharma in 2021.

Astellas' Bernie Zeiher on the power of inclusive and diverse teams

Bernie Zeiher is the Chief Medical Officer at Astellas Pharma. Bernie spoke to us about making decisions with the patient in mind, the power of inclusive and diverse teams, and the importance of curiosity and continuous learning

The digital culture wars

How can the industry create a culture that integrates digital transformation within organisations and unites people under a common purpose?

Boosting pharma sales rep’s virtual confidence

During the COVID-19 pandemic, pharmaceutical sales reps have been forced to navigate the virtual playing field, and as they operate in this new territory, their confidence is wavering.

The gender health gap

How can pharma better engage with male patients and encourage them to become more proactive when it comes to looking after their own health?

Talking to Karen Moyse

Karen Moyse, Founder and Managing Director, KineticFuture Leadership, discusses best practices for managing conflicting personalities.

Talking to Isma Benattia

Isma Benattia, Vice President Europe Medical Affairs, Amgen talks about harnessing technology to unlock better outcomes for patients.

Talking to Arun Mahtani

Arun Mahtani, Former Vice President, Channels Strategy and Digital Content, Teva Pharmaceuticals, talks about impactful patient initiatives.

Talking to Kumaran Krishnan

Kumaran Krishnan, Director, Medical Excellence and Digital Transformation, Teva, discusses unlocking further potential in developed markets.